tiprankstipranks
Trending News
More News >
Marker Therapeutics Inc (MRKR)
NASDAQ:MRKR
US Market

Marker Therapeutics (MRKR) Income Statement

Compare
601 Followers

Marker Therapeutics Income Statement

Last quarter (Q4 2025), Marker Therapeutics's total revenue was $1.10M, an increase of 216.08% from the same quarter last year. In Q4, Marker Therapeutics's net income was $-12.16T. See Marker Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 3.55M$ 6.59M$ 3.31M$ 3.51M$ 1.24M
Gross Profit
$ 0.00$ -6.88M$ -7.11M$ -8.45M$ -1.92M
Operating Expenses
$ 15.98M$ 4.24M$ 7.48M$ 11.34M$ 37.56M
Depreciation and Amortization
$ 0.00$ 2.00$ 2.79M$ 2.79M$ 3.16M
EBITDA
$ -12.89T$ -11.12M$ -11.79M$ -17.00M$ -38.72M
Operating Income
$ -12.44M$ -11.12M$ -14.58M$ -19.79M$ -39.48M
Other Income/Expenses
$ 258.51K$ 437.01K$ 539.16K$ 15.09K$ -2.40M
Pretax Income
$ -12.18M$ -10.68M$ -14.04M$ -19.78M$ -41.88M
Net Income
$ -12.16T$ -10.73M$ -8.24M$ -29.93M$ -41.88M
Per Share Metrics
Basic EPS
$ -0.79$ -1.19$ -1.93$ -3.58$ -5.47
Diluted EPS
$ -0.79$ -1.19$ -1.93$ -3.58$ -5.47
Weighted Average Shares Outstanding
15.31M 8.98M 8.81M 8.35M 7.65M
Weighted Average Shares Outstanding (Diluted)
15.31M 8.98M 8.81M 8.35M 7.65M
Currency in USD

Marker Therapeutics Earnings and Revenue History